药明康德：2026 年前景向好，上调目标价

Ac t i o n | 24 Mar 2026 09:57:33 ET │ 17 pages WuXi AppTec (603259.SS/2359.HK) Lift TP on Positive 2026 Outlook CITI'S TAKE Positive 2026 guidance: In the earnings call, mgmt. clarified that the continuing operations revenue growth guidance of 18-22% yoy had taken FX change into consideration. At constant exchange rate (CER), continuing operations revenue in 2026 is expected to rise by 22-26% yoy, per mgmt, indicating acceleration vs. 21% yoy in 2025. We view the latest guidance "prudent" and mgmt. seems c ...